ISTANBUL escrs

Crossed versus conventional pseudophakic monovision: patient satisfaction, visual function and spectacle independence comparison

Session Details

Session Title: Cataract 1
Session Date/Time: Friday 20/02/2015 | 10:30-12:30
Paper Time: 11:02
Venue: Sadirvan B
First Author: : F.Zhang USA
Co Author(s): :    A. Sugar   L. Arbisser   G. Jacobsen   J. Artico     

Abstract Details

Purpose:

To compare patient satisfaction, visual function and spectacle independence in patients with crossed and conventional pseudophakic monovision.

Setting:

Department of Ophthalmology, Henry Ford Health System, Taylor branch, Michigan, USA.

Methods:

7,311 cataract surgery patient records from June 1999 to December 2013 were reviewed. Forty-four crossed monovision patients were identified and 30 of them were enrolled in this study. Thirty control conventional monovision cases were matched for age, gender, general health, personal life style/main hobbies, pre-operative refractive status, and post-operative refractive status, UCDVA and UCNVA, astigmatism level, and anisometropia level. A survey was mailed out to participants and results were independently analyzed.

Results:

Thirty matched pairs were surveyed. Mean anisometropia was 1.19 D in the conventional and 1.12 D in the crossed monovision groups. No significant difference was identified for eye-hand coordination, eye-foot coordination, or sport related depth perception, but satisfaction was slightly better in the crossed monovision group (p=0.028) No significant difference was identified for 6 of 8 spectacle independence measures, but nighttime driving was a little bit easier for the crossed monovision group (p=0.025) . 77 % of crossed and 50% of conventional monovision patients did not use glasses for intermediate distance activities. (p=0.037)

Conclusions:

Crossed pseudophakic monovision appears to work as well as conventional pseudophakic monovision in terms of patient satisfaction, visual function and spectacle independence in patients with a mild degree of anisometropic pseudophakia.

Financial Disclosure:

NONE

Back to previous